How to Treat Rosacea: Step-by-Step Plan by Severity

This is the action plan. If you’ve already read up on rosacea and want a clear stepwise protocol — what to start with, when to escalate, what not to do, and how to tell if it’s working — this is the page for that. We’ve structured it by severity (mild, moderate, severe) and by sequence (week one through week twelve, plus maintenance) so you can find the part that matches you.

For the comprehensive treatment landscape — the full menu of every available topical, oral, procedural, and adjunctive option, with the evidence base for each — see our companion rosacea treatment pillar. This page is the patient-action version of that material; it is opinionated about sequence and tradeoffs, where the comprehensive pillar is exhaustive about options.

At a glance

• Week 1–2 (everyone): strip the routine to gentle cleanser + bland moisturizer + mineral SPF. Stop every active. Start a structured trigger diary.
• Week 2–8 (mild rosacea): add azelaic acid 10% (OTC) or 15% (Rx) if papulopustules are present. Continue trigger management. Photograph weekly.
• Week 4 (everyone): if not improving, escalate. The fastest path to control is a dermatology appointment with photographs in hand.
• Moderate rosacea (Rx topicals + supportive): prescription azelaic acid, ivermectin, metronidazole, or minocycline foam ± oral doxycycline 40 mg modified-release.
• Severe rosacea (combination Rx + procedural): combine topical and oral; add brimonidine or oxymetazoline for erythema; vascular laser/IPL for telangiectasias; isotretinoin for refractory PPR.
• Maintenance: lower-intensity continuation of what worked. Stop early and the rosacea returns; over-treat and you irritate the skin. The maintenance routine is its own discipline.
• What NOT to do: stack actives during a flare, switch products weekly, use topical steroids on the face, or self-discontinue an effective medication because the skin “looks better.”

---

Step zero: confirm it’s actually rosacea

Before treating, be reasonably sure of the diagnosis. The two conditions that most commonly get misidentified as rosacea are:

• Adult acne. Has comedones (blackheads, closed-comedone whiteheads). Rosacea does not. If you have comedones, treat as acne (or both).
• Perioral dermatitis. Concentrated around the mouth, nose, and eyes; often associated with topical steroid use, fluorinated toothpaste, or specific cosmetic ingredients. Treatment overlaps with rosacea but the entity is distinct.

Other conditions that mimic rosacea include contact dermatitis, photodamage, lupus erythematosus (the classic malar rash), seborrheic dermatitis, polycythemia, and (rarely) carcinoid syndrome and mastocytosis. If your “rosacea” has features outside the typical centrofacial pattern — sudden onset, asymmetric, accompanied by systemic symptoms (palpitations, diarrhea, weight loss), or unresponsive to anything you try — get a clinical evaluation before continuing self-treatment. See our rosacea vs acne and dermatitis and redness 101: rosacea vs irritation primers for the disambiguation.

If you’re not sure which type of rosacea you have, our types of rosacea pillar walks through the four classical subtypes and the modern phenotype-based approach.

---

Week 1–2: the universal reset

Whatever the severity, the first two weeks of any rosacea treatment plan look the same. The job is to take the skin back to baseline, remove every potential aggravator, and give yourself a clean starting point from which to add things back deliberately.

The reset routine (twice daily):

1. Cleanse: non-foaming, fragrance-free cream cleanser. Lukewarm water. Pat dry. Examples: CeraVe Hydrating Cleanser, Avène Tolérance Extrêmement Gentle Cleanser.
2. Moisturize: ceramide- or glycerin-based, fragrance-free, alcohol-free. Examples: Vanicream Moisturizing Cream, CeraVe Moisturizing Cream, Bioderma Sensibio AR+ Cream.
3. Sunscreen (AM only): mineral, SPF 30+, fragrance-free. Tinted is generally better tolerated and includes iron oxides for visible-light protection. Examples: La Roche-Posay Anthelios Mineral Tinted Ultra Fluid SPF 50, Colorescience Face Shield Flex SPF 50.

What to stop, completely, for these two weeks:

• Vitamin C serums (especially L-ascorbic acid)
• Retinol / retinoid products of any concentration
• Glycolic, lactic, or salicylic acid products
• Physical scrubs of any kind
• Niacinamide above 5% (lower is fine)
• Any “brightening,” “exfoliating,” “resurfacing,” or “anti-aging” product
• Any fragranced product
• Hot water on the face — lukewarm only, including in the shower
• Any cosmetic procedure (peels, microneedling, laser, etc.)

What to add:

• A structured trigger diary. For two weeks, log what you eat and drink (rough temperature), alcohol, sleep hours, subjective stress (0–10), weather, exercise, and any flushing or flare with severity (0–10). Take a face photo each morning in the same lighting and angle. We have a printable diary linked in every page footer (/downloads/rosacea-trigger-diary.pdf). For the methodology see rosacea triggers: the short list that matters.

The point of the reset is to know what your skin actually looks like when you’re not provoking it. Many patients are surprised by how much their baseline improves on the reset alone — that improvement is the floor from which the rest of the treatment plan operates.

For the longer treatment of how to build a calm routine, see a gentle routine for redness-prone skin and rosacea self-care: a simple flare plan.

---

Mild rosacea (weeks 2–8)

You have mild rosacea if, after the reset, you have:

• Occasional flushing (a few times per month, not daily)
• Mild diffuse central erythema that you can mostly cover with a tinted sunscreen
• Few or no inflammatory papules and pustules
• No phymatous changes
• No significant ocular symptoms

For mild rosacea, the treatment plan is largely self-directed and centred on lifestyle and a single OTC active.

Continue: the reset routine. Cleanser, moisturizer, mineral sunscreen.

Add (week 2 onward): if you have any inflammatory papules or pustules at all, add an OTC azelaic acid 10% serum (such as The Ordinary Azelaic Acid Suspension 10% or Paula’s Choice 10% Azelaic Booster). Apply once daily in the evening, after moisturizer. Increase to twice daily after one week if tolerated. Give it eight weeks before judging — this is a slow active. See our azelaic acid for rosacea full guide for the protocol.

If you have no papules or pustules and your main complaint is diffuse erythema, do not add azelaic acid — it does not target your problem effectively. Focus on trigger management and consider whether you want to discuss vascular laser or topical brimonidine with a dermatologist (see “Moderate” section below).

Apply trigger management aggressively. Mild rosacea responds disproportionately well to honest trigger management. Identify your top one or two triggers from the diary, eliminate them, and watch the diary numbers. Most patients can reduce monthly flare counts by 50% or more with disciplined trigger management alone.

Re-evaluate at week 8. Take photos. Compare to your week-zero photos. Categorize: better (continue), same (escalate), worse (escalate immediately).

If you’re better at week 8, continue the routine into maintenance (see below).

If you’re the same or worse at week 8, escalate to the moderate plan or book a dermatology appointment.

---

Moderate rosacea (Rx topicals + supportive)

You have moderate rosacea if:

• Flushing is frequent (multiple times per week or daily)
• Central erythema is persistent and noticeable
• You have meaningful papulopustular involvement (more than a few bumps, persistent over weeks)
• You have begun to notice telangiectasias (visible small blood vessels) on the cheeks or nose
• OR you completed the mild plan and didn’t get adequate improvement

Moderate rosacea generally requires prescription medications. The single highest-leverage step at this stage is a dermatology appointment.

Bring to the appointment:

• Your trigger diary (the one you’ve kept for the past 4+ weeks)
• Your week-zero, week-4, and week-8 photographs in the same lighting
• Your current OTC routine including specific product names
• A list of any medications you take (some, like topical steroids on the face, are common contributors)

The prescription tier for moderate rosacea — what your dermatologist may prescribe:

For papulopustular features:

• Topical azelaic acid 15% gel or foam (Finacea, generic). First-line for many derms. Anti-inflammatory and modestly antibacterial. Twice daily.
• Topical ivermectin 1% cream (Soolantra). Targets the Demodex population, which is elevated in rosacea-prone skin. Often produces striking results over 12 weeks. Once daily. See our Demodex mites and rosacea explainer for the mechanism.
• Topical metronidazole 0.75–1% (Metrogel, MetroCream, Rosadan). Modest efficacy, very well tolerated. Twice daily.
• Topical minocycline foam 1.5% (FMX103, Zilxi). Newer; useful when oral antibiotics are not appropriate.

For more inflammatory papulopustular involvement, often added to topicals:

• Oral doxycycline 40 mg modified-release (Oracea, Apprilon). Sub-antimicrobial dose used for the anti-inflammatory effect. Standard for moderate-to-severe PPR. The sub-antimicrobial dosing minimizes antibiotic resistance concerns. Generally taken for 12–16 weeks initially, then re-evaluated.

For erythema and flushing features:

• Topical brimonidine 0.33% gel (Mirvaso). Alpha-2 agonist; vasoconstricts cutaneous vessels. Onset within an hour, lasts 8–12 hours. Side effect: rebound flushing as it wears off (in some patients severe). Trial cautiously and start with a small test area on the cheek before applying across the face.
• Topical oxymetazoline 1% cream (Rhofade). Alpha-1 agonist with similar mechanism, generally less rebound than brimonidine.

Continue the supportive routine. The cleanser, moisturizer, and mineral sunscreen do not stop because you’ve added prescriptions. They support the skin against the irritation potential of the actives, and they remain the foundation of the maintenance plan once the prescriptions taper.

Re-evaluate at week 12 of the moderate plan. Photograph. Most moderate rosacea patients show meaningful improvement in this window. If you’re not improving, the plan needs adjustment — escalate to a derm reassessment, not to “just more of the same for longer.”

For the comprehensive treatment landscape including all the medication options, dosing details, and procedural choices, see our companion rosacea treatment pillar.

---

Severe rosacea (combination Rx + procedural)

You have severe rosacea if:

• Flushing is daily and disabling
• Central erythema is severe and persistent
• You have dense papulopustular involvement (clusters of bumps and pustules, persistent over months)
• You have prominent telangiectasias affecting overall skin appearance
• You have phymatous changes (thickening, irregular surface, particularly on the nose)
• You have ocular involvement with vision changes, severe photophobia, or recurrent corneal involvement
• OR you completed the moderate plan with adequate adherence and didn’t get adequate improvement

Severe rosacea is not a self-treatment situation. The plan involves multiple specialists, combination therapy, and often procedural intervention. The job at this stage is to get the right team in place and adhere to the plan they design.

The combination approach for severe rosacea typically involves:

1. Aggressive topical regimen. Often a combination — topical ivermectin in the morning, topical azelaic acid 15% in the evening, with a topical alpha-agonist for daytime erythema control on key days.
2. Oral therapy. Doxycycline 40 mg modified-release or, in refractory cases, low-dose isotretinoin (0.25–0.3 mg/kg/day for 4–6 months). Isotretinoin requires close monitoring (monthly labs, pregnancy prevention if applicable, mood monitoring) and is initiated by a dermatologist.
3. Vascular laser or IPL for the persistent erythema and telangiectasias. Pulsed-dye laser (595 nm), KTP laser (532 nm), or IPL (with vascular filter). Three to five sessions, spaced 4–6 weeks apart. Results last years but are not permanent. The procedure does not target the underlying inflammatory drive — it addresses the visible vascular component while medication addresses the inflammation.
4. Procedural debulking for established phymatous changes. CO₂ laser ablation, electrosurgery, dermabrasion, or surgical paring depending on the location and severity. Performed by a dermatologic or plastic surgeon experienced with rosacea. See our rosacea on the nose / rhinophyma overview for the longer discussion.
5. Ophthalmologic management for ocular features, including lid hygiene, warm compresses, artificial tears, topical or oral antibiotics, and topical cyclosporine or lifitegrast where appropriate. See ocular rosacea.

Realistic expectations for severe rosacea:

• Meaningful improvement is achievable in nearly all severe cases, but it takes longer (6–12 months) than mild or moderate disease.
• The goal is control, not cure. Severe rosacea is rarely permanently resolved; the maintenance regimen is generally lifelong.
• Combination therapy is expensive and demanding. Plan for it.
• Mental health matters. Severe rosacea is associated with significant psychosocial impact (anxiety, depression, social withdrawal). The 2023 mind-body review by Mar and Rivers (PMID 37898903) discusses the bidirectional relationship — rosacea affects mental health, and stress meaningfully worsens rosacea. Address both.

---

Maintenance — the routine that keeps you stable

Once you’ve achieved control of your rosacea, the next decision is how to maintain it. Stop everything and most patients relapse within months. Continue everything at the treatment intensity and you risk over-irritating skin that is now stable.

The maintenance principle: continue what you’ve shown is effective, at the lowest intensity that holds the gains.

For mild rosacea who responded to the OTC plan:

• Continue gentle cleanser, bland moisturizer, mineral sunscreen daily — indefinitely.
• Continue OTC azelaic acid 10% if you used it, but consider tapering to once-daily or to a maintenance frequency (Mon/Wed/Fri) after 12 weeks of stable skin.
• Continue trigger management on the high-leverage personal triggers identified during the diary phase.
• Re-introduce other actives slowly and one at a time — vitamin C, retinoids — with careful monitoring.

For moderate rosacea who responded to topical Rx:

• Continue the supportive routine indefinitely.
• Most dermatologists will taper topical metronidazole or azelaic acid to once-daily after 12 weeks of clear skin, then to alternate-day after another 12 weeks, then to as-needed for early flare signs.
• Topical ivermectin is often continued as a maintenance once-daily or alternate-day regimen for many months.
• If you needed oral doxycycline, the typical course is 12–16 weeks; transition to topical-only maintenance with re-introduction of oral therapy at the first sign of relapse.

For severe rosacea after combination treatment:

• The maintenance regimen is generally agreed in conversation with the dermatologist. Most severe rosacea patients continue some level of topical therapy permanently, with periodic vascular laser touch-ups every 2–3 years to maintain the results of the initial laser series.

General maintenance rules:

• Photograph monthly in the same lighting. Memory drifts; photos do not.
• Re-introduce other actives slowly, one at a time, with at least four weeks between additions.
• The first sign of a flare is the cue to step back up the ladder, not to add something new on top of an already-failing routine.
• Re-do the trigger diary every 6–12 months. Triggers can shift over time as life circumstances change.

---

What NOT to do

Don’t stack actives during a flare. A flare is the signal to subtract, not to add. Strip back to the universal reset routine until the flare settles for at least seven consecutive days, then add back one product at a time.

Don’t switch products every week. Most rosacea actives need eight weeks to show effect. Switching every two weeks because “it’s not working yet” guarantees you never give anything time to work.

Don’t use topical corticosteroids on the face for rosacea. Topical steroids appear to help short-term and reliably backfire over weeks to months, producing steroid rosacea — a rosacea-like eruption that’s harder to treat than the original problem. Topical steroids on the face for any reason should be a deliberate, time-limited, dermatologist-supervised decision.

Don’t self-discontinue an effective medication “because it’s working.” Many patients stop topical ivermectin or oral doxycycline once the skin clears, then return four weeks later with a flare. The medication is what’s keeping the skin clear. Tapering decisions belong to the dermatology relationship, not to the bathroom mirror.

Don’t trust supplement marketing. No oral supplement has rigorous evidence for treating rosacea. Generic probiotics, omega-3, niacinamide capsules, “anti-inflammatory” formulations — none of these have data approaching what the established prescription regimens have. If you have GI symptoms warranting workup, get the workup; if you don’t, the supplement aisle is unlikely to help.

Don’t use food as a moral framework. “I deserved this flare because I ate a piece of cake” is not a clinically useful or psychologically healthy way to think about rosacea. Triggers are information, not punishment. See our rosacea diet & triggers pillar for the longer treatment.

Don’t treat ocular symptoms as separate from facial rosacea. Around 50% of facial rosacea patients have at least some ocular involvement. Gritty eyes, recurrent styes, and reflex tearing in a rosacea patient are ocular rosacea until proven otherwise — get them evaluated alongside the skin.

Don’t skip mineral sunscreen “because it’s winter.” UV exposure is a year-round trigger and the evidence for daily sunscreen as a foundational rosacea management step is independent of season.

---

When to escalate to a dermatologist

Don’t wait for catastrophe. Escalate to a dermatology appointment if:

• You completed the universal reset and 8 weeks of mild-rosacea treatment without meaningful improvement
• You have any phymatous changes (thickening on the nose or central face) at all
• You have any eye symptoms — gritty feeling, recurrent styes, blurred vision, light sensitivity
• Your flushing pattern is severe, sudden-onset, asymmetric, or accompanied by systemic symptoms (palpitations, diarrhea, weight loss)
• You’re considering vascular laser or IPL
• You’ve been treated for “rosacea” for over a year without meaningful improvement (the diagnosis or the plan needs reassessment)
• You have significant psychosocial distress related to your skin

For more on what to bring to the appointment and what to expect, see when to see a rosacea dermatologist.

---

Frequently asked questions

How long does rosacea treatment take to work?

Topical treatments generally need 8–12 weeks before you can fairly judge them. Oral doxycycline at sub-antimicrobial dose typically shows initial benefit at 4 weeks and continues improving through 12 weeks. Vascular laser results appear over 4–6 weeks after each session. Plan for months, not weeks.

Can rosacea be cured?

Not currently. Rosacea is a chronic condition; the realistic goal is control, not cure. With a good plan, most patients achieve meaningful and durable improvement. With consistent maintenance, that improvement holds. Discontinuing an effective regimen typically leads to relapse within weeks to months.

Can mild rosacea be treated without prescription medication?

Yes, in many cases. The universal reset (gentle cleanser, bland moisturizer, mineral sunscreen) plus disciplined trigger management plus, if appropriate, OTC azelaic acid 10% gives many mild rosacea patients adequate control. If after eight weeks of consistent OTC treatment you’re not improving, escalate.

What if I can’t afford prescription medications?

Several of the foundational rosacea medications are now generic. Topical metronidazole, oral doxycycline (the standard 100 mg form, though not the modified-release Oracea), and 15% azelaic acid in a generic gel are all relatively affordable in most countries. Discuss the budget constraint openly with your dermatologist — they know which formulations cost what locally, and the difference between brand and generic for many of these medications is meaningful.

Should I try natural or alternative remedies first?

A few — colloidal oatmeal moisturizers, green tea topical, niacinamide — have modest evidence and are reasonable. Most “natural” rosacea remedies (apple cider vinegar, essential oils, raw honey applied to the face) range from “no evidence” to “actively harmful” for rosacea-prone skin. The genuinely natural intervention with the strongest evidence is trigger management. Putting a fragranced essential oil on your face is not a natural remedy; it’s a fragrance challenge dressed up in marketing.

Can I treat rosacea while pregnant?

Yes, with adjustments. The default options during pregnancy are: gentle skincare, mineral sunscreen, and topical azelaic acid (Pregnancy Category B in the US system). Topical metronidazole has more limited safety data in pregnancy and is typically avoided. Oral doxycycline is contraindicated. Topical ivermectin has limited data and is typically avoided. Brimonidine and oxymetazoline have limited data; discuss with your dermatologist and obstetrician. Isotretinoin is absolutely contraindicated during pregnancy.

Will my rosacea come back if I stop treatment?

Very likely, yes. Rosacea is chronic. The maintenance routine is what holds the gains. Patients who discontinue effective treatment typically relapse within weeks to months. The maintenance regimen can usually be lower-intensity than the active treatment regimen, but it shouldn’t be zero.

Is laser treatment for rosacea worth it?

For the visible telangiectasias and persistent baseline erythema of erythematotelangiectatic features, vascular laser (pulsed-dye, KTP) and IPL have strong evidence and produce results that medications cannot match. The treatment is moderately expensive, requires multiple sessions, and provides durable but not permanent improvement. For patients whose primary concern is visible redness, it is often the highest-impact intervention available.

Can I use makeup over my rosacea treatment?

Yes — and most patients prefer to. Apply your topical treatment, wait 10–15 minutes for it to absorb, apply moisturizer if used, then sunscreen, then makeup. Choose green-tinted color correctors and avoid shimmer, fragrance, and alcohol-forward products. See our best products for rosacea pillar for specific product recommendations in the coverage category.

What’s the difference between treating mild and severe rosacea?

The medications, the duration, and the involvement of specialists. Mild rosacea is often handled with OTC products and lifestyle changes. Moderate adds prescription topicals and possibly oral doxycycline. Severe combines aggressive topical and oral medication with procedural intervention (vascular laser, occasionally surgical debulking) and frequent dermatology follow-up. The supportive routine (cleanser, moisturizer, mineral sunscreen) remains the same across all severity levels.

How do I know if my rosacea is getting better?

Photograph weekly in the same lighting and angle. Track three things: baseline erythema severity (0–10), papulopustule count, and flare days per week. Memory is unreliable; photos and counts are not. Most rosacea improvement is gradual enough that you won’t notice it day-to-day but will see it clearly in 4-week comparisons.

What should I do if my treatment stops working?

First, examine adherence honestly — the most common reason “the medication stopped working” is that the patient stopped using it as prescribed. If adherence is solid and the regimen has lost effect, the next step is dermatology re-evaluation. Don’t escalate dose or add other actives independently; the right move is reassessment, which may include checking the diagnosis, considering whether a new trigger has entered the picture, and adjusting the regimen.

Is it safe to use topical steroids “just for a few days” during a flare?

No. Topical steroids on the face for rosacea consistently produce a “feel better short-term, much worse over weeks” pattern, with steroid rosacea as the long-term consequence. The right move during a flare is to subtract irritants, not add a steroid.

Sources

• Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, Lynde CW, Marcoux D, Poulin Y, Rivers JK, Sapijaszko M, Sibbald RG, Toole J, Ulmer M, Zip C. Canadian Clinical Practice Guidelines for Rosacea. J Cutan Med Surg. 2016 Sep;20(5):432-45. PubMed PMID 27207355.
• Mar K, Rivers JK. The Mind Body Connection in Dermatologic Conditions: A Literature Review. J Cutan Med Surg. 2023 Nov;27(6):628-640. PubMed PMID 37898903.
• Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020 May;182(5):1269-1276. PubMed PMID 31392722.
• Tan J, Almeida LMC, Bewley A, Cribier B, Dlova NC, Gallo R, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017 Feb;176(2):431-438. PubMed PMID 27718519.
• van Zuuren EJ, Fedorowicz Z, Tan J, van der Linden MMD, Arents BWM, Carter B, Charland L. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 2019 Jul;181(1):65-79. PubMed PMID 30585305.
• Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015 May;72(5):761-70. PubMed PMID 25890456.
• Del Rosso JQ, Tanghetti E, Webster G, Stein Gold L, Thiboutot D, Gallo RL. Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl 1):S17-S24. PubMed PMID 32802255.
• Rivers JK, Arlette JP, DeKoven J, Guenther LC, Muhn C, Richer V, Rosen N, Tremblay JF, Wiseman MC, Zip C, Zloty D. Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic. SAGE Open Med. 2021;9:20503121211062795. PubMed PMID 34917384.
• Sbidian E, Vicaut É, Chidiack H, Anselin E, Cribier B, Dréno B, Chosidow O. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea. J Invest Dermatol. 2016 Jun;136(6):1124-1129. PubMed PMID 26967483.

---

Educational content. Not a substitute for individualized medical advice. The treatment approaches described here should be implemented in conversation with a clinician familiar with your specific case.